Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

Elias Campo, Elaine S. Jaffe, James R. Cook, Leticia Quintanilla-Martinez, Steven H. Swerdlow, Kenneth C. Anderson, Pierre Brousset, Lorenzo Cerroni, Laurence de Leval, Stefan Dirnhofer, Ahmet Dogan, Andrew L. Feldman, Falko Fend, Jonathan W. Friedberg, Philippe Gaulard, Paolo Ghia, Steven M. Horwitz, Rebecca L. King, Gilles Salles, Jesus San-Miguel, John F. Seymour, Steven P. Treon, Julie M. Vose, Emanuele Zucca, Ranjana Advani, Stephen Ansell, Wing-Yan Au, Carlos Barrionuevo, Leif Bergsagel, Wing C. Chan, Jeffrey I. Cohen, Francesco d’Amore, Andrew Davies, Brunangelo Falini, Irene M. Ghobrial, John R. Goodlad, John G. Gribben, Eric D. Hsi, Brad S. Kahl, Won-Seog Kim, Shaji Kumar, Ann S. LaCasce, Camille Laurent, Georg Lenz, John P. Leonard, Michael P. Link, Armando Lopez-Guillermo, Maria Victoria Mateos, Elizabeth Macintyre, Ari M. Melnick, Franck Morschhauser, Shigeo Nakamura, Marina Narbaitz, Astrid Pavlovsky, Stefano A. Pileri, Miguel Piris, Barbara Pro, Vincent Rajkumar, Steven T. Rosen, Birgitta Sander, Laurie Sehn, Margaret A. Shipp, Sonali M. Smith, Louis M. Staudt, Catherine Thieblemont, Thomas Tousseyn, Wyndham H. Wilson, Tadashi Yoshino, Pier-Luigi Zinzani, Martin Dreyling, David W. Scott, Jane N. Winter, Andrew D. Zelenetz

Blood (2022) 140 (11): 1229–1253.

https://doi.org/10.1182/blood.2022015851

Published: 2022

Includes: Supplemental data

Journal Articles

Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines

Christopher Pleyer, Mir A. Ali, Jeffrey I. Cohen, Xin Tian, Susan Soto, Inhye E. Ahn, Erika M. Gaglione, Pia Nierman, Gerald E. Marti, Charles Hesdorffer, Jennifer Lotter, Jeanine Superata, Adrian Wiestner, Clare Sun

Blood (2021) 137 (2): 185–189.

https://doi.org/10.1182/blood.2020008758

Published: 2021

Includes: Supplemental data

Journal Articles

SARS-CoV-2–specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein

Blood (2020) 136 (25): 2905–2917.

https://doi.org/10.1182/blood.2020008488

Published: 2020

Includes: Supplemental data

Journal Articles

Hydroa vacciniforme–like lymphoproliferative disorder: an EBV disease with a low risk of systemic illness in whites

Blood (2019) 133 (26): 2753–2764.

https://doi.org/10.1182/blood.2018893750

Published: 2019

Includes: Supplemental data

Journal Articles

How I treat T-cell chronic active Epstein-Barr virus disease

Catherine M. Bollard, Jeffrey I. Cohen

Blood (2018) 131 (26): 2899–2905.

https://doi.org/10.1182/blood-2018-03-785931

Published: 2018

Journal Articles

Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56 bright subset

Emily M. Mace, Amy P. Hsu, Linda Monaco-Shawver, George Makedonas, Joshua B. Rosen, Lesia Dropulic, Jeffrey I. Cohen, Eugene P. Frenkel, John C. Bagwell, John L. Sullivan, Christine A. Biron, Christine Spalding, Christa S. Zerbe, Gulbu Uzel, Steven M. Holland, Jordan S. Orange

Blood (2013) 121 (14): 2669–2677.

https://doi.org/10.1182/blood-2012-09-453969

Published: 2013

Includes: Supplemental data

Journal Articles

Chronic active Epstein-Barr virus infection: a novel cause of lymphocytic variant hypereosinophilic syndrome

Amy D. Klion, Rojelio Mejia, Edward W. Cowen, Kennichi C. Dowdell, Kieron Dunleavy, Gary A. Fahle, Nicole Holland-Thomas, Irina Maric, Stefania Pittaluga, Mark Raffeld, Carlo Santos, Maryalice Stetler-Stevenson, Tammy Krogmann, Amber N. Shatzer, Siu-Ping Turk, Yuzhi Yin, Liqiang Xi, Calman Prussin, Jeffrey I. Cohen

Blood (2013) 121 (12): 2364–2366.

https://doi.org/10.1182/blood-2012-12-472720

Published: 2013

Journal Articles

Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States

Blood (2011) 117 (22): 5835–5849.

https://doi.org/10.1182/blood-2010-11-316745

Published: 2011

Includes: Supplemental data

Journal Articles

Detection of EBV genomes in plasmablasts/plasma cells and non-B cells in the blood of most patients with EBV lymphoproliferative disorders by using Immuno-FISH

Sara Calattini, Irini Sereti, Philip Scheinberg, Hiroshi Kimura, Richard W. Childs, Jeffrey I. Cohen

Blood (2010) 116 (22): 4546–4559.

https://doi.org/10.1182/blood-2010-05-285452

Published: 2010

Includes: Supplemental data

Journal Articles

Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome

Kennichi C. Dowdell, Julie E. Niemela, Susan Price, Joie Davis, Ronald L. Hornung, João Bosco Oliveira, Jennifer M. Puck, Elaine S. Jaffe, Stefania Pittaluga, Jeffrey I. Cohen, Thomas A. Fleisher, V. Koneti Rao

Blood (2010) 115 (25): 5164–5169.

https://doi.org/10.1182/blood-2010-01-263145

Published: 2010

Includes: Supplemental data

Journal Articles

Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia

Phillip Scheinberg, Steven H. Fischer, Li Li, Olga Nunez, Colin O. Wu, Elaine M. Sloand, Jeffrey I. Cohen, Neal S. Young, A. John Barrett

Blood (2006) 109 (8): 3219–3224.

https://doi.org/10.1182/blood-2006-09-045625

Published: 2006

Journal Articles

Preliminary Results of a Phase I/II Trial of BBR-2778 (Pixantrone) in Combination with Fludarabine, Dexamethasone, and Rituximab (FPD-R) in the Treatment of Patients with Relapsed/Refractory Indolent Non-Hodgkin’s Lymphoma (NHL).

Luis Fayad, M.D, James Liebmann, M.D, Manuel Modiano, M.D, Gary I. Cohen, M.D, Barbara Pro, M.D, Jorge Romaguera, M.D, Cristina Davite, BSc, Margarita Lymboura, BSc, Silvia Comis, M.D, Bernard L. Laffranchi, M.D

Blood (2004) 104 (11): 1324.

https://doi.org/10.1182/blood.V104.11.1324.1324

Published: 2004

Journal Articles

Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation

Harutaka Katano, Mir A. Ali, Andriani C. Patera, Marta Catalfamo, Elaine S. Jaffe, Hiroshi Kimura, Janet K. Dale, Stephen E. Straus, Jeffrey I. Cohen

Blood (2004) 103 (4): 1244–1252.

https://doi.org/10.1182/blood-2003-06-2171

Published: 2004

Journal Articles

Alloantigen-Stimulated Anti-HIV Activity

Ligia A. Pinto, Sandra Sharpe, David I. Cohen, Gene M. Shearer

Blood (1998) 92 (9): 3346–3354.

https://doi.org/10.1182/blood.V92.9.3346

Published: 1998

Journal Articles

The effect of peptides and monoclonal antibodies that bind to platelet glycoprotein IIb-IIIa complex on the development of clot tension

I Cohen, DL Burk, JG White

Blood (1989) 73 (7): 1880–1887.

https://doi.org/10.1182/blood.V73.7.1880.1880

Published: 1989

Journal Articles

Disulfide-linked and transglutaminase-catalyzed protein assemblies in platelets

I Cohen, CT Lim, DR Kahn, T Glaser, JM Gerrard, JG White

Blood (1985) 66 (1): 143–151.

https://doi.org/10.1182/blood.V66.1.143.143

Published: 1985

Journal Articles

Hematin: unique effects of hemostasis

R Glueck, D Green, I Cohen, CH Ts'ao

Blood (1983) 61 (2): 243–249.

https://doi.org/10.1182/blood.V61.2.243.243

Published: 1983

Journal Articles

Brief Note: The Free Amino Acid Changes in Plasma Following Coagulation and Plasminogen Activation

SAUL I. COHEN

Blood (1959) 14 (12): 1345–1349.

https://doi.org/10.1182/blood.V14.12.1345.1345

Published: 1959

NARROW

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines

SARS-CoV-2–specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein

Hydroa vacciniforme–like lymphoproliferative disorder: an EBV disease with a low risk of systemic illness in whites

How I treat T-cell chronic active Epstein-Barr virus disease

Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56 bright subset

Chronic active Epstein-Barr virus infection: a novel cause of lymphocytic variant hypereosinophilic syndrome

Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States

Detection of EBV genomes in plasmablasts/plasma cells and non-B cells in the blood of most patients with EBV lymphoproliferative disorders by using Immuno-FISH

Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome

Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia

Preliminary Results of a Phase I/II Trial of BBR-2778 (Pixantrone) in Combination with Fludarabine, Dexamethasone, and Rituximab (FPD-R) in the Treatment of Patients with Relapsed/Refractory Indolent Non-Hodgkin’s Lymphoma (NHL).

Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation

Alloantigen-Stimulated Anti-HIV Activity

The effect of peptides and monoclonal antibodies that bind to platelet glycoprotein IIb-IIIa complex on the development of clot tension

Disulfide-linked and transglutaminase-catalyzed protein assemblies in platelets

Hematin: unique effects of hemostasis

Brief Note: The Free Amino Acid Changes in Plasma Following Coagulation and Plasminogen Activation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only